IMA Evaluations LLC dba IMA Clinical Research
IMA Clinical Research is a patient-centric, flexible clinical trial network dedicated to advancing medical treatments through site-based, hybrid, and decentralized trials. With extensive geographic reach and a focus on diversity, the company aims to improve healthcare access and develop new therapies efficiently. The company actively conducts clinical trials across various therapeutic areas, including depression, sleep disorders, cardiovascular diseases, and more, adapting to evolving legal landscapes such as cannabis research.
Industries
Nr. of Employees
large (251-1000)
IMA Evaluations LLC dba IMA Clinical Research
660 White Plains Rd, Suite 630, Tarrytown, NY 10591
Products
Participant registry / patient database
A centralized registry of individuals interested in clinical trials (several hundred thousand records) used to screen and recruit participants for studies.
Integrated clinical trial management platform
An integrated CTMS used to coordinate study operations, track enrollments and manage site workflows across a multisite network.
Participant registry / patient database
A centralized registry of individuals interested in clinical trials (several hundred thousand records) used to screen and recruit participants for studies.
Integrated clinical trial management platform
An integrated CTMS used to coordinate study operations, track enrollments and manage site workflows across a multisite network.
Services
Operational delivery of site-based, hybrid and decentralized clinical trials across a nationwide network of full-service and satellite sites.
Contact center operations, targeted recruitment campaigns and use of a centralized participant registry and community partnerships to increase enrollment and diversity.
Centralized contracting, regulatory start-up support and operational processes to accelerate site activation and study startup across a multisite network.
Deployment of mobile research units and community screening events to perform diagnostic exams, lab work and imaging to identify eligible participants and reduce barriers to enrollment.
Evaluation and redesign of existing clinical facilities for research readiness, including rapid reconfiguration to support new study launches and infection-control modifications.
Provision of non-invasive liver screening (transient elastography), laboratory-based biomarker assessments and cardiovascular risk testing to support study screening and community outreach.
Operational delivery of site-based, hybrid and decentralized clinical trials across a nationwide network of full-service and satellite sites.
Contact center operations, targeted recruitment campaigns and use of a centralized participant registry and community partnerships to increase enrollment and diversity.
Centralized contracting, regulatory start-up support and operational processes to accelerate site activation and study startup across a multisite network.
Deployment of mobile research units and community screening events to perform diagnostic exams, lab work and imaging to identify eligible participants and reduce barriers to enrollment.
Evaluation and redesign of existing clinical facilities for research readiness, including rapid reconfiguration to support new study launches and infection-control modifications.
Provision of non-invasive liver screening (transient elastography), laboratory-based biomarker assessments and cardiovascular risk testing to support study screening and community outreach.
Expertise Areas
- Clinical trial management (Phase II–IV and post-market)
- Decentralized and hybrid clinical trial delivery
- Patient recruitment, outreach and retention
- Site selection, conversion and rapid startup
Key Technologies
- Clinical trial management systems (CTMS)
- Participant-facing portals and recruitment databases
- Telehealth and remote visit infrastructure
- Transient elastography (non-invasive liver stiffness measurement)
News & Updates
Reflecting on a year of growth, milestones, and opportunities that laid the foundation for an even stronger 2025, including team achievements, expansions, and strategic initiatives.
Insights from Dr. Gazda on innovative approaches to depression treatment and ongoing research efforts.
Recognition for excellence in clinical trial management and contribution to vaccine research.
Reflecting on a year of growth, milestones, and opportunities that laid the foundation for an even stronger 2025, including team achievements, expansions, and strategic initiatives.
Insights from Dr. Gazda on innovative approaches to depression treatment and ongoing research efforts.
Recognition for excellence in clinical trial management and contribution to vaccine research.